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DNA methylation: addition of a methyl group to a cytosine base residue in DNA,
often localised next to a guanine base. Methylated cytosines can be further
modified by hydroxylation. Methylated cytosines can lead to the recruitment
of specific methyl DNA-binding proteins, which may lead to transcriptional
repression.
Epigenetic: heritable changes in gene expression that do not involve changes
in the DNA sequence.
Epigenome: the epigenetic state of the genome.
Histone modifications: histones are the basic unit of the nucleosome and are
subjected to a large number of post-translational modifications, which play an
important role in regulating chromatin structure and, hence, regulation of gene
expression. Both histone tails and core residues can be subjected to
modifications as diverse as acetylation, methylation, phosphorylation and
ubiquitinylation, to cite a few.
Histone variants:most histone variants are distinguishable from core histones
by a few amino acid changes or by a larger non-histone domain. These
divergences confer important functions on histone variants and therefore add
to the complexity of epigenetic regulation. Histone variants can replace core
histones in a nucleosome.
Induction of pluripotency: refers to pluripotent stem cells that have been
reprogrammed from somatic cells by forced expression of specific transcrip-
tion factors.
Noncoding RNAs: RNAs that are encoded by genes, but are not translated into
proteins. Instead, their structure allows them to interact functionally with
various biochemical processes, such as translation, transcription and chroma-
tin structure.
Nuclear reprogramming: changes in gene activity that are induced experimen-
tally by exposing a nucleus to a new environment.
Nuclear transfer: the transfer of one or multiple cell nuclei into eggs or oocytes.
The transplantation of a somatic cell nucleus into an enucleated egg
(metaphase II oocytes) can lead to the development of a cloned embryo. The
technique is often referred to as SCNT. The transfer of multiple nuclei into the
nucleus of a Xenopus oocyte (meiotic prophase I) leads to transcriptional
reactivation of quiescent genes.
Pluripotency: the capacity of a cell to generate most of the cell lineages of the
body, including germ cells but excluding extra-embryonic lineages.
Somatic memory: persistent characteristic of differentiated cells present in
reprogrammed cells. The memory results from the incomplete erasure of thePatient-specific somatic cell reprogramming is likely to
have a large impact onmedicine by providing a source of
cells for disease modelling and regenerative medicine.
Several strategies can be used to reprogram cells, yet
they are generally characterised by a low reprogram-
ming efficiency, reflecting the remarkable stability of the
differentiated state. Transcription factors, chromatin
modifications, and noncoding RNAs can increase the
efficiency of reprogramming. However, the success of
nuclear reprogramming is limited by epigenetic mecha-
nisms that stabilise the state of gene expression in
somatic cells and thereby resist efficient reprogram-
ming. We review here the factors that influence repro-
gramming efficiency, especially those that restrict the
natural reprogramming mechanisms of eggs and
oocytes. We see this as a step towards understanding
the mechanisms by which nuclear reprogramming takes
place.
Routes towards nuclear reprogramming
The differentiated state of somatic cells in an organism is
remarkably stable. Cells do not normally change from one
differentiation pathway to another. However, adult somat-
ic cells can be experimentally reprogrammed into other cell
types, including pluripotent stem cells. By this route, the
new cells obtained are genetically equivalent to the cells of
origin and, similar to embryonic stem (ES) cells, can be
induced to differentiate into any specialised cell type.
Nuclear reprogramming (see Glossary) has great potential
in terms of its medical application and, for this reason,
many efforts have been made to increase its efficiency and
to understand the mechanisms by which it occurs. Repro-
grammed cells from patients can be used to study diseases
in ways not previously possible and to design novel drug
screens. Furthermore, reprogrammed cells could also pro-
vide a source of patient-matched replacement cells.
Different systems have been used to reprogram cells
(Figure 1). These include nuclear transfer to eggs and
oocytes, cell fusion and overexpression of transcription
factors. The nucleus of a specialised cell can be repro-
grammed by somatic cell nuclear transfer (SCNT) to an§ This is an open-access article distributed under the terms of the Creative Com-
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see also [4]). In this case, a somatic cell nucleus is repro-
grammed by the egg to behave like the nucleus of an
embryonic cell, and cells of the resulting embryo are plu-
ripotent and able to differentiate into many, and some-
times all, cell types unrelated to the original donor nucleus
(Figure 1a). The transcriptional state of somatic cell nuclei
can also be reprogrammed by nuclear transfer to Xenopus
meiotic prophase I oocytes (Figure 1b) [5]. Another route is
to fuse two cells from different origins in such a way thatsomatic cell epigenome.
Transcription factors: proteins that bind to specific DNA sequences to control
gene expression. Transcription factors can form multiprotein complexes and bind
regulatory regions to control the recruitment and activity of RNA polymerases.
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Figure 1. Different strategies induce nuclear reprogramming towards pluripotency. (a) During reprogramming by nuclear transfer to eggs, the nucleus of a cell is
transplanted into an unfertilised egg whose own nucleus has been removed [1]. The resulting embryos, larvae and adults have the same genetic constitution as the donor
nucleus. The animal and vegetal poles of the egg are shown in brown and yellow, respectively. (b) For nuclear reprogramming by nuclear transfer to Xenopus oocytes,
multiple mammalian nuclei are transplanted into the nucleus (germinal vesicle) of a meiotic prophase I oocyte [5]. Transcriptional reactivation of previously silenced genes
is induced without cell division or DNA synthesis, and no new cell types are formed. The animal and vegetal poles of the oocyte are shown in brown and yellow,
respectively. (c) The nuclei of distinct cell types can be induced to reside within a common cytoplasm [8]. The fused cells form heterokaryons, in which the nuclei remain as
separate entities, and these can be maintained by inhibiting cell division. (d) Pluripotency can be induced in cultured somatic cells by overexpression of embryonic stem
(ES) cell-specific transcription factors or by overexpression of small noncoding RNAs together with histone deacetylases inhibitors [11,58]. The cells obtained are very
similar to ES cells. Adapted, with permission, from [14].
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cytoplasm; such fused cells form heterokaryons and cell
hybrids (Figure 1c) [6–10]. In heterokaryons, the nuclei
remain as separate entities within a common cytoplasm for
a few days [8]. In proliferating cell hybrids, progression
through the cell cycle causes the nuclei to fuse and give rise
to synkaryons, which we do not discuss here. In hetero-
karyons, the nucleus of one donor cell is induced to express
genes characteristic of the other donor cell, thereby pro-
viding an opportunity to investigate the mechanism of
reprogramming. The cells fused can be of different species
or differentiation state. For example, mouse ES cells can be
fused to human fibroblasts [9]. Pluripotency can be induced
in somatic cells by overexpression of a few transcription
factors, originally Oct4, Sox2 (both of which are required
for pluripotency), Klf4 and c-Myc (Figure 1d) [11]. The
induced pluripotent stem (iPS) cells obtained have been
well reviewed by others [12,13]. However, regardless of the
system used, the proportion of nuclei or cells that are
reprogrammed to new cell types is always low. This shows
the resistance of somatic cells to reprogramming and
reflects the stability of the differentiated state. Here, we
concentrate on the epigenetic factors that promote or
restrict the success or efficiency of nuclear reprogramming.
Efficiency of nuclear reprogramming
To understand the mechanisms of nuclear reprogramming
and resistance to it, one needs to be able to judge the
efficiencies of the various procedures; that is, the proportionof the starting cell population that responds to a reprogram-
ming condition. If this proportion is very small, and if those
cells that respond cannot be distinguished from those that
do not, it is very hard to identify reprogramming factors and
mechanisms. This is because most cells may not undergo
reprogramming. There are striking differences in the speed
andefficiencyof reprogrammingbydifferentproceduresand
in resistance to it. There are two kinds of evidence for
resistance to reprogramming. One comes from comparing
nuclei from more or less differentiated cells; the other from
comparingnuclei ofdifferent cell types.Theefficiencyof, and
resistance to, nuclear reprogramming can bemeasured by
many criteria. We have previously reviewed the criteria
that can be used to judge reprogramming efficiency else-
where [14].Here,we only use the formation of different cell
types or transcription of pluripotency genes as criteria
(Figure 2).
When somatic cell nuclei are transplanted to enucleated
eggs (in second meiotic metaphase), the efficiency with
which new cell types are generated decreases by over
10-fold, as the donor cells from which nuclei are taken
become more differentiated (Figure 2a). For example, the
proportion of total nuclear transfers to Xenopus eggs that
reach the swimming larval stage (with functional muscle
and nerve) goes down from 35% with donor cells at the
gastrula stage to 1.7% from tadpole intestinal epithelial
cells, a decrease of up to 20 times [15]. In mice, the success
of nuclear transfers from ES cells compared to those from
adult fibroblasts decreases by 10-fold from 10–20% to517
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Figure 2. Resistance to reprogramming increases as cells differentiate. The extent of resistance to reprogramming (equivalent to a decrease in reprogramming efficiency)
as cells differentiate, when tested by nuclear transfer (a–c), cell fusion (heterokaryon) (d) and induced pluripotency (e). Reproduced, with permission, from [15] (a), [16] (b),
[5] (c), [19] (d) (but also see [100,101]) and [22] (e). Abbreviations: ES, embryonic stem; ESRA, retinoic-acid differentiated embryonic stem cells.
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transfers that reach birth, as reviewed in [16] (Figure 2b),
(but also see [17]). A similar decrease in success rate is seen
with nuclear transfers to Xenopus oocytes (first meiotic
prophase), when judged by pluripotency gene activation
from transplanted nuclei. For example, the absolute
number ofSox2 pluripotency gene transcripts synthesised
per transplanted nucleus per day goes from 7200 for
differentiated ES cells to 160 for thymus, a decrease of
40-fold (Figure 2c) [5]. A similar decrease is seen for Oct4
transcripts.518To determine the efficiency of reprogramming in cell
fusion experiments, the most informative are those that
result in heterokaryons. Efficiency can be assessed as the
proportion of selected heterokaryons (1–2% of total fusions
attempted) that express pluripotency genes, such as Oct4.
Transcription of such genes can be detected in 70% of
the heterokaryons (mouse ES and human fibroblasts)
within one day [9], although the level of this expression
is likely to be low (i.e. approximately 1% of the expression
of these genes in ES cells) [18]. When one donor cell is
highly differentiated, a lower proportion of heterokaryons
Review Trends in Genetics December 2011, Vol. 27, No. 12activate some of the genes that are not expressed in the
starting somatic cells [19]. For example, the proportion of
heterokaryons that are induced to express the human
muscle gene 5.1H11 6 days following fusion with mouse
muscle cells is 95% for human lung fibroblasts, 60% for
human keratinocytes and 25% for human hepatocytes
(Figure 2d) [19]. We conclude that, in heterokaryons, as
in nuclear transfers, nuclei from the most specialised cells
are much more resistant to reprogramming than those of
less specialised cells.
The overall efficiency of derivation of iPS cells by tran-
scription factor overexpression is low (0.01% to approxi-
mately 6% of the treated cells) [11,12,20,21], but can be
increased by various means, including noncoding RNAs,
culture conditions, and so on. Transcription factor over-
expression induces iPS cells approximately 20 times less
often when immature T cells are compared to thymic
progenitor cells, and approximately 300 times less effi-
ciently when mature peripheral T cells are compared to
thymic progenitors (Figure 2e) [22].
Resistance to reprogramming is also very evident when
donor nuclei from different cell types are compared. In
nuclear transfer to Xenopus oocyte experiments, ten times
more transcripts ofSox2 aremade by transplanted nuclei of
mouse embryonic fibroblasts (MEFs) than by those of the
more differentiated C2C12 cells [5]. Conversely, the tran-
scripts of Oct4 and Nanog are five to eight times more
abundant in transplanted C2C12 nuclei compared to nuclei
of mouse embryo fibroblasts [5]. The difference between
these two cell types in resistance is therefore at least 50-
fold in respect of these genes. Because the reprogramming
factors of an oocyte are the same for both kinds of nucleus,Table 1. Cellular factors that influence nuclear reprogramming
Factors
Promote
Transcription factors Oct4, Sox2, Klf4, c
Chromatin decondensation and remodelling Histone B4, nucle
Brg1, BAF155, Ch
DNA demethylation AID
Tet3
H3K9me2/3 demethylation Kdm3a, Kdm4c
Trithorax proteins Wdr5
Polycomb proteins PRC2: Eeda, Ring1
Cell division Mitosis
DNA replication
Small noncoding RNAs miR-291-3p, miR-2
miR-93, miR-106b
Long noncoding RNAs Long noncoding R
Restrict
DNA methylation Dnmt1
Dnmt1
Histone deacetylation Hdac
Hdac
H3K9me2/3 methylation LOCKs, G9a
G9a
G9a
Histone variants macroH2A
aEed and Ring1b were demonstrated to be required in ES cells for their ability to induce
lymphocytes [32].the 50-fold difference in responsiveness reflects the differ-
ential resistance of these genes in the two donor cell types.
Another aspect of resistance to reprogramming comes
from the phenomenon of epigenetic memory, when differ-
ent cell types are compared. In both nuclear transfer to egg
experiments [23] and induced pluripotency work [24,25],
reprogrammed nuclei and cells show persistent expression
of genes that were active in donor cells, even though such
genes are not normally transcribed in the derived cell
types. In these cases, active genes resist a switch off after
nuclear transfer or induced pluripotency, and this resis-
tance can continue for numerous cell divisions.
The conclusion from this section is that there is a strong
correlation between the more differentiated state of a cell
and its resistance to reprogramming. Resistance is also
seen when comparing the activation of quiescent genes in
different cell types. We propose that this resistance to
reprogramming reflects the stability of the differentiated
state, and is the result of the progressive acquisition of
epigenetic restrictions during embryonic development. We
now review the epigenetic mechanisms that could account
for this resistance and stability. Table 1 lists factors known
to promote or restrict nuclear reprogramming.
Epigenetic barriers to nuclear reprogramming
Chromatin decondensation
The compaction of DNA in somatic cells is thought to be
inhibitory to reprogramming. The first level of DNA com-
paction is defined by the wrapping of DNA around nucleo-
somes [26]. The presence of nucleosomes can prevent
binding of certain transcriptional regulators, for example
to DNA binding sites and, in particular, to large DNASystem Refs
-Myc, Nanog Induced pluripotency [11,12,102]
oplasmin Nuclear transfer [30,33]
d1 Induced pluripotency [37–39]
Cell fusion [9]
Nuclear transfer [47]
Cell fusion [67]
Induced pluripotency [63]
ba Cell fusion [32,103]a
Induced pluripotency [89,93,94]
Nuclear transfer [89,95,96]
94, miR-295,
, miR302/367
Induced pluripotency [58,86–88]
NA-RoR Induced pluripotency [85]
Nuclear transfer [43,46]
Induced pluripotency [25,44]
Nuclear transfer [51,55,56]
Induced pluripotency [57,58]
Nuclear transfer [64,66]
Induced pluripotency [68]
Cell fusion [67]
Nuclear transfer [51]
transcriptional reprogramming of pluripotency genes following fusion with human
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requires mobilisation and remodelling of nucleosomes to
allow transcriptional regulators to gain access to their
genomic targets [27]. Consistent with this, most of the
factors with the ability to promote access to gene regulatory
regions have been found to be able to increase reprogram-
ming efficiencies (Table 1) [28].
As cells differentiate, their chromatin becomes increas-
ingly condensed.Nuclear volume is indicative of the average
extent of chromatin condensation. We estimate the volume
of a nucleus (inversely related to condensation) in lympho-
cytes, non-mammalian red blood cells, and sperm, to be
three, eight or 100 times respectively, smaller than that of
an ES cell. In all nuclear transfer experiments, both in eggs
and oocytes, a nuclear volume increase of 10–30-fold accom-
panies new gene transcripts [29], chromosomal proteins
leave the nucleus and chromosomal protein mobility is
increased [30]. Likewise, in heterokaryon experiments, sim-
ilar changes follow cell fusion [6,7,31]. However, changes in
nuclear volumes are not sufficient for gene reactivation
because Polycomb-deficient ES cells do not induce pluripo-
tency gene reactivationwhen fused to humanB-lymphocytes
but nuclear volume changes remain unperturbed [32]. In
Figure 3, we present a hypothetical model of chromosomal
changes associated with nuclear reprogramming.
Two components of eggs and oocytes that seem partic-
ularly important for chromatin decondensation are
[(Figure_3)TD$FIG]
Figure 3. Hypothetical model of chromatin state changes at gene regulatory regions du
states requires several events, some of which are summarised here. A fully repressed
histone variants such as macroH2A and multiple repressive histone modifications. Once
ability to recruit activities, such as H3K4 methyltransferases. Loss of repressive hist
demethylation may occur actively or passively through cell divisions. Histone acetylatio
transcriptional silencing of differentiation genes during reprogramming towards pluri
representedmay occur simultaneously and/or in a different order according to the gene a
reprogramming may not be in the exact reverse order of the events that occur during
520nucleoplasmin (a chaperone of histones H2A and H2B)
[33], and a special oocyte-specific linker histone named B4
for amphibians or H1foo for mammals [34,35]. B4 incor-
poration into nuclei transplanted to Xenopus oocytes is
complete in few hours, and is necessary for pluripotency
gene activation [30]. We interpret these results as indi-
cating an opening of chromatin structure to expose those
genes that are quiescent in somatic cells to the transcrip-
tional-activating components of eggs and oocytes. In the
case of eggs and oocytes, the opening up of chromosome
structure after nuclear transfer may well be global; that
is, not gene specific. Supporting this view is the fact that
a wide range of genes, including lineage-specific genes
normally expressed in muscle, nerve, and so on, start to
be transcribed in somatic nuclei transplanted to Xenopus
oocytes [36]. Although reprogramming to induced pluri-
potency may be mechanistically different, the chromatin
remodelling enzymeChd1 has been shown to be important
for the induction and maintenance of pluripotency by
promoting an open chromatin state [37]. Chromatin remo-
dellers Brg1 and Baf155 have been found to increase
the efficiency of Oct4-GFP reactivation during induction
of pluripotency from mouse embryonic fibroblasts (MEFs)
[38], in addition to egg extract work [39].
We suggest that chromatin decondensation and loss of
chromosomal proteins is a primary event that is required,
but not sufficient for reprogramming and thereforering reprogramming and differentiation. Epigenetic reprogramming of chromatin
gene (a) must be remodelled to evict repressive nucleosomes, which may contain
accessible, regulatory regions may be bound by transcriptional regulators with the
one modifications, such as H3K9me2/3, H3K27me2/3 and DNA methylation and
n also strongly increases transcriptional activity (b). The opposite route may lead to
potency, or silencing of pluripotency genes during cell differentiation. The steps
nd system considered. The order of the epigenetic events that occur during nuclear
cell differentiation.
Review Trends in Genetics December 2011, Vol. 27, No. 12counteracts differentiation-related resistance. Different
reprogramming systems seem to use different ways to
promote chromatin decondensation.
DNA demethylation
The best-known epigenetic mechanism that imposes a
roadblock to nuclear reprogramming is DNA methylation.
Reprogramming by nuclear transfer, by cell fusion and by
induced pluripotency is associated with a global reversal of
DNA methylation so that somatic nuclei closely resemble
those of ES cells [9,24,40–42]. DNA demethylation of re-
pressed genes is required for gene reactivation during
reprogramming [9,43,44] and the failure of this has been
correlated with poor development of cloned embryos [45].
Derivation of mouse ES cells by nuclear transfer is more
efficient when the donor nuclei lack DNA methyltransfer-
ase 1 (Dnmt1), an enzyme needed for DNA methylation
[46] and the transient inhibition of Dnmt1 has also been
found to help the transition from partially to fully repro-
grammed iPS cells (Table 1) [25,44]. Therefore, DNA de-
methylation is a key step during nuclear reprogramming,
although it is not clear how much of it results from active
DNA demethylation versus passive loss through cell divi-
sions. Eggs and oocytes seem to induce DNA demethyla-
tion more efficiently than does transcription factor-based
reprogramming [24]. The mechanisms of active DNA de-
methylation are currently being unravelled and include
hydroxylation of methylated cytosines by Tet enzymes and/
or deamination by AID/APOBECs followed by DNA repair
[9,47,48].
The whole-genome profiling of DNA methylation in iPS
cells and in ES cells derived by nuclear transfer reveals
that an incomplete reversal of DNA methylation takes
place in reprogrammed cells, indicating that, in such cells,
reprogramming is not fully efficient [24,49,50]. Incomplete
DNA demethylation clearly contributes resistance to
reprogramming.
It is important to appreciate that there are instances in
which a resistance to reprogramming is not fully explained
by DNA methylation alone. The inactive X chromosome of
female mammalian cells is commonly associated with
methylated DNA. By contrast, the inactive X chromosome
of female mouse epiblast stem cells is methylated yet it can
be reactivated by nuclear transfer to Xenopus oocytes,
whereas the inactive X of MEFs, also methylated, is resis-
tant to reactivation [51]. DNA methylation only restricts
transcription in specific chromatin contexts [52], for exam-
ple in promoters, where it may directly prevent transcrip-
tion factor binding or promote DNA compaction.
Furthermore, methylated plasmid DNA is perfectly well
transcribed in Xenopus oocytes until it becomes chroma-
tinised and hypoacetylated through the recruitment of
histone deacetylases (Hdac) [53]. Themain conclusion here
is that DNA demethylation takes place during nuclear
reprogramming, but is incompletely effective and so can
cause resistance to successful reprogramming.
Histone modifications and histone variants
Histone tails are subject to numerous post-translational
modifications that are important for the regulation of
chromatin structure and gene expression [54]. Histonedeacetylation commonly accompanies gene repression in
differentiated cells. Inhibitors of Hdac, including valproic
acid (VPA) and trichostatin A (TSA) often promote the
success of nuclear reprogramming (Table 1) [55–57]. For
example, the frequency of obtaining cloned offspring by
nuclear transfer to mammalian eggs is improved up to
fivefold by Hdac inhibition [55,56]. Gene reactivation is
also enhanced by Hdac inhibition in induced pluripotency
experiments [57]. The downregulation of Hdac2 allows the
induction of pluripotency from MEFs solely by expression
of miR302/367 [58]. It may be that an inhibition of differ-
entiation programs, together with appropriate culture con-
ditions, may be sufficient for the induction of pluripotency.
In Caenorhabditis elegans, expression of the gustatory
neurons inducing transcription factor CHE-1 together
with either Hdac inhibition or the deletion of the histone
chaperone lin-53 allows reprogramming of germ cells
into neurons [59]. No other cell type is affected by CHE-
1 overexpression, an indication that, in C. elegans, certain
chromatin factors can provide a cell type-specific resis-
tance to reprogramming [59]. Altogether, inhibiting Hdac
activity generally improves reprogramming.
The ‘active’ histone mark H3K4me2/3 is important for
transcription initiation and activity [60] and is associated
with transcriptional gene reactivation after somatic cell
nuclear transfer to Xenopus oocytes [61]. In agreement
with this, in induced pluripotency experiments,
H3K4me2 is deposited before the first cell division and
prior to signs of transcriptional activation at a subset of
genes [62]. It is thought that this event may increase
accessibility of regulatory regions of DNA. The Trithorax
proteinWdr5, an effector of H3K4methylation, was shown
to be required for the formation of iPS cells (Table 1) [63].
Other histone marks are associated with gene repres-
sion and undergo large changes during nuclear reprogram-
ming. The maintenance of large chromatin blocks
containing H3K9me2 (LOCKs) is associated with epigenet-
ic memory, which increases resistance to nuclear repro-
gramming [64,65]. The H3K9me2/3 methyltransferase
G9a has been shown to restrict reprogramming in part
through DNA methylation [66]. In agreement, the expres-
sion of the H3K9me3 demethylaseKdm3a or G9a removal,
both increase the efficiency of reprogramming following
nuclear transfer and cell fusion (Table 1) [66,67]. H3K9me3
inhibitors, such as BIX-01294, also increase the efficiency
of iPS cells derivation [68].
The histone variant macroH2A is commonly associated
with heterochromatin in vertebrates and is usually incor-
porated after gene silencing has been induced [69]. Inter-
estingly, eggs contain an activity that removes macroH2A
from the nucleus after fertilisation and after nuclear trans-
fer [70,71]. The knock-down of macroH2A in MEFs
increases the transcriptional reprogramming efficiency
of Oct4 and Sox2 in Xenopus oocytes [51]; therefore
macroH2A seems to cooperate with other silencing mech-
anisms to maintain the repressed state of genes in somatic
cells and so helps to account for resistance to reprogram-
ming. It is thought that macroH2A may directly restrict
reprogramming by preventing transcription factor binding
[72], by preventing histone acetylation, and by recruiting
Hdacs [73,74]. macroH2A also seems to reduce the affinity521
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these complexes being thought to be required for nucleo-
some mobility and hence for access of factors to repressed
genes.
Transcriptional components that promote or restrict
reprogramming
In reprogramming experiments when new cell types are
not formed (Xenopus oocytes and heterokaryons), the tran-
scription of pluripotency and other genes is used as a
measure of successful reprogramming (Figure 1). In nuclei
transplanted to Xenopus oocytes, the rate of transcription
of such genes increases greatly from an undetectable level
in donor cells to 1200 (or 170) new transcripts per gene per
day for Sox2 (or Oct4) [5]. The mechanism of this tran-
scriptional activation is known to be related to an excep-
tionally high content of transcriptional components in
Xenopus oocytes. This includes enough polymerase II for
the transcription of over 10 000 somatic nuclei [76,77], as
happens when normal Xenopus embryos reach the stage of
transcriptional activation (the blastula stage) [78]. All
polymerase II in the blastula is thought to be derived from
the oocyte content [77]. Histone H3.3 is closely associated
with active transcription [79] and is exceptionally abun-
dant in oocytes (G. Almouzni, personal communication).
Also, a high content of polymerised actin is characteristic of
the oocyte germinal vesicle; it is present in somatic nuclei
that are reprogrammed by Xenopus oocytes, and is re-
quired for successful transcriptional reprogramming
[80]. Therefore the exceptionally high content of transcrip-
tional components in the oocyte germinal vesicle helps to
account for the transcriptional activation of genes in trans-
planted nuclei.
We think that the resistance of somatic nuclei to tran-
scriptional reprogramming by oocytes can be explained
by the condensed state of chromatin. It is known that
the rate of transcription increases enormously as the chro-
matin of nuclei transplanted to Xenopus oocytes becomes
decondensed, and does so in direct proportion to nuclear
volume increase [81]. As the chromatin of nuclei becomes
decondensed in injected oocytes, polymerase II and other
transcriptional components gain access to previously
quiescent genes.
The high content of histone H3.3, a transcription-relat-
ed histone variant, may account for the phenomenon of
epigenetic memory, mentioned above, in which somatic
nuclei transplanted to Xenopus eggs resist the switching
off of genes active in donor cells [23]. For example, muscle-
specific genes are actively transcribed in the nuclei of
muscle cells. The unusually high H3.3 content in eggs
may promote the continuing transcription of such genes
in developing embryos in non-muscle cells, in a way that
would not happen in sperm after fertilisation, because
sperm nuclei do not have active muscle genes.
There is recent evidence that numerous noncoding
RNAs are important regulators of transcriptional and
epigenetic states [82]. The noncoding RNA Xist plays a
role in inducing the transcriptional inactivation of a female
mammalian X chromosome [83]. In the mouse, half of the
genes that resist reprogramming in nuclear transfer em-
bryos are located on the inactive X chromosome [64,84].522These embryos aberrantly express Xist on the active X
chromosome, leading to aberrant inactivation of X-linked
genes [64]. In this case, resistance to gene activation is
caused by the mis-regulation of a noncoding RNA that now
guides the silencing machinery to chromatin. The deletion
of one copy ofXist from donor nuclei is sufficient to decrease
resistance and so increase the efficiency of cloned offspring
derivation by nuclear transfer. It seems probable that
other noncoding RNAs, short or long, may also contribute
resistance to reprogramming (Table 1). One study identi-
fied a set of long noncoding RNAs upregulated during
reprogramming to pluripotency; one of these facilitates
reprogramming [85]. Several groups have reported that
interference with the RNAi machinery can significantly
alter reprogramming, and that the introduction of specific
miRNAs can help iPS cell derivation [58,86–88].
Cell division helps but is not required
When new cell types are formed after reprogramming in
nuclear transfer to eggs and in induced pluripotency
experiments, extensive cell division always takes place
before new cell types appear. It has been speculated that
cell division might contribute to reprogramming, possibly
through the replacement of chromosomal proteins at mi-
tosis or by the assimilation of new chromosomal proteins
during DNA synthesis [89]. However, reprogramming as
judged by new gene transcription clearly does not require
cell division or DNA synthesis, because these do not take
place in oocyte nuclear transfer or in heterokaryon experi-
ments [5,19,90]. It is also known that DNA demethylation
can occur in the absence of cell division [9,43,91]. In
another example, the conversion of C. elegans Y epithelial
cells into motoneurons can occur in the absence of cell
division [92]. Nevertheless, cell divisions seem to facilitate
reprogramming in systems where they occur and may be
required for a full level of transcription and for the gener-
ation of new cell types [93,94]. The resetting of replication
origins from a somatic type to an embryonic one is seen
when somatic nuclei are incubated in oocyte extract,
suggesting that this is important for reprogramming by
nuclear transfer [95,96].
Concluding remarks and future perspectives
The cytoplasm of eggs, somatic and pluripotent cells, or
ectopically expressed factors, can reprogram the nucleus
of many kinds of somatic cell, so that gene expression
(of these nuclei) is switched to that characteristic of the
initial cytoplasmic cell type. Mechanisms of reprogram-
ming include chromatin decondensation and remodelling,
DNA demethylation, histone modifications and changes in
the rate of transcription of many genes (including those
required for pluripotency). As cells become more differen-
tiated, their nuclei become increasingly resistant to repro-
gramming. Resistance seems to depend on the acquisition
of a combination of several epigenetic factors, each of which
contributes to the stability of the differentiated state. Eggs,
oocytes, somatic cells or ES-cell-specific factors are incom-
pletely efficient at reversing these stabilising factors.
We think that reprogramming may be different for
induced pluripotency by transcription factor overexpres-
sion compared to nuclear transfer and cell fusion. The
Box 1. Nuclear reprogramming events required to yield new
cell types
(i) Chromatin decondensation
(ii) Loss of differentiation marks
(iii) Transcriptional activation
(iv) Cell division
(v) Suppression of competing cell lineages*
In the case of nuclear transfer to second meiotic metaphase eggs
and induced pluripotency by transcription factor overexpression, all
five steps take place in an overlapping time sequence. By contrast,
these reprogramming steps seem to be separate in nuclear transfer
to Xenopus oocyte (first meiotic prophase) experiments in which
only steps i-iii take place. The five steps shown may occur in a
different order.
* For cells to follow a differentiation pathway correctly, other competing path-
ways may need to be suppressed.
Review Trends in Genetics December 2011, Vol. 27, No. 12former may be achieved by a stochastic vacancy of tran-
scription factor binding sites in otherwise undisturbed
chromatin [94,97–99]. Nuclear transfer and cell fusion
do not involve transcription factor overexpression, but
need chromatin remodelling.
Although different reprogramming systems may use
different routes to achieve reprogramming, we think that
five steps are required for the complete switch from a
differentiated somatic cell to an embryonic cell or to an
unrelated differentiated cell by nuclear transfer, cell fusion
or induced pluripotency (Box 1). In the case of nuclear
transfer to second meiotic metaphase eggs and induced
pluripotency by transcription factor overexpression, all five
steps take place in an overlapping time sequence. By
contrast, these reprogramming steps seem to be separate
in nuclear transfer to Xenopus oocyte (first meiotic pro-
phase) experiments in which only steps i–iii take place.
Cell division (step iv) and suppression of competing path-
ways (step v) occur only as eggs divide and as different cell
lineages begin to appear. However, resistance to repro-
gramming is clearly evident in oocyte nuclear transfer
experiments in the absence of cell division. We conclude
that resistance to reprogramming in nuclear transfer
experiments is caused, at least in part, by incomplete
chromatin decondensation, incomplete removal of differ-
entiation chromatin marks and, hence, by incomplete
transcriptional activation. As cells differentiate, they pro-
gressively acquire more and more epigenetic marks that
restrict reprogramming. Although oocytes are endowed
with components that promote nuclear reprogramming,
it may be that the process of cell differentiation progres-
sively compacts the chromatin of specialised cells, in par-
ticular that of quiescent genes, so that access to important
genes is a slow process.
A mechanistic understanding of the epigenetic factors
that restrict reprogramming in different systems is only
starting to emerge. Identifying the epigenetic factors and
understanding the mechanisms that restrict somatic cell
nuclear reprogramming is one important aim for the repro-
gramming field, in addition to finding ways of removing
these restrictions efficiently from somatic cells. This will be
required to generate efficiently useful replacement (stem)
cells to be used for therapy.Acknowledgements
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